Renaissance Technologies LLC Buys 282,300 Shares of Select Medical Holdings Co. (NYSE:SEM)

Renaissance Technologies LLC boosted its holdings in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 1,206.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 305,700 shares of the health services provider's stock after buying an additional 282,300 shares during the quarter. Renaissance Technologies LLC owned approximately 0.24% of Select Medical worth $5,762,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. LPL Financial LLC boosted its stake in shares of Select Medical by 2.0% during the 4th quarter. LPL Financial LLC now owns 31,441 shares of the health services provider's stock worth $593,000 after acquiring an additional 619 shares during the period. Bank of Montreal Can boosted its position in Select Medical by 4.5% during the fourth quarter. Bank of Montreal Can now owns 20,030 shares of the health services provider's stock worth $378,000 after purchasing an additional 867 shares during the period. Sippican Capital Advisors increased its holdings in shares of Select Medical by 7.3% in the fourth quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider's stock valued at $252,000 after purchasing an additional 912 shares during the last quarter. State of New Jersey Common Pension Fund D raised its position in shares of Select Medical by 2.2% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 56,719 shares of the health services provider's stock valued at $1,069,000 after purchasing an additional 1,234 shares during the period. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after buying an additional 1,473 shares during the last quarter. Institutional investors own 89.48% of the company's stock.

Select Medical Price Performance

Shares of SEM traded up $0.29 during mid-day trading on Thursday, reaching $16.60. The company had a trading volume of 53,284 shares, compared to its average volume of 815,627. The company's 50 day simple moving average is $17.11 and its 200 day simple moving average is $22.61. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of 10.05, a P/E/G ratio of 0.64 and a beta of 1.38. Select Medical Holdings Co. has a 1-year low of $14.99 and a 1-year high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd were paid a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.51%. The ex-dividend date was Monday, March 3rd. Select Medical's dividend payout ratio is currently 15.15%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. UBS Group lowered their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, January 3rd. Mizuho began coverage on Select Medical in a research report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective on the stock. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research report on Monday, February 24th. Royal Bank of Canada dropped their price objective on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research note on Monday, February 24th. Finally, StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $26.80.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.